The FDA gives the green light to the first gene therapy for deafness

Sierra Smith holds her son, Travis, whose deafness was successfully treated with gene therapy.

The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.